2140264-81-7

Basic information

• Product Name: C₁₇H₂₃NO₄
• CAS NO: 2140264-81-7
• Molecular Weight: 305.374
• Mol File: 2140264-81-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: C₁₇H₂₃NO₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₇H₂₃NO₄(2140264-81-7)
• EPA Substance Registry System: C₁₇H₂₃NO₄(2140264-81-7)

Safety Data

• Hazardous Substances Data: 2140264-81-7(Hazardous Substances Data)

Upstream product

• 939758-05-1 cis-methyl 4-phenylpyrrolidine-3-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 221142-28-5 (±)-trans-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid 
• 186581-53-3 diazomethane 
• 951742-87-3 (3R,4R)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid 
• 221142-28-5 1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 874367-19-8 C₁₂H₁₅NO₂*ClH 

Relevant articles and documents

AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN

The present invention relates to new compounds that show pharmacological activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the μ-opiod receptor (MOR or mu-opioid). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.

Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids

The present invention relates to a process for the preparation of cis substituted cyclic β-aryl or heteroaryl carboxylic acid derivatives in high diastereo- and enantioselectivity by enantioselective hydrogenation in accordance with the following scheme w